These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 21851536)
1. Analysis of regional lymph nodes in periprostatic fat following robot-assisted radical prostatectomy. Yuh B; Wu H; Ruel N; Wilson T BJU Int; 2012 Feb; 109(4):603-7. PubMed ID: 21851536 [TBL] [Abstract][Full Text] [Related]
2. Pathological analysis of lymph nodes in anterior prostatic fat excised at robot-assisted radical prostatectomy. Aning JJ; Thurairaja R; Gillatt DA; Koupparis AJ; Rowe EW; Oxley J J Clin Pathol; 2014 Sep; 67(9):787-91. PubMed ID: 24996431 [TBL] [Abstract][Full Text] [Related]
3. The impact of robotic surgery on pelvic lymph node dissection during radical prostatectomy for localized prostate cancer: the Brown University early robotic experience. Yates J; Haleblian G; Stein B; Miller B; Renzulli J; Pareek G Can J Urol; 2009 Oct; 16(5):4842-6. PubMed ID: 19796462 [TBL] [Abstract][Full Text] [Related]
4. Extended vs standard lymph node dissection in robot-assisted radical prostatectomy for intermediate- or high-risk prostate cancer: a propensity-score-matching analysis. Kim KH; Lim SK; Kim HY; Shin TY; Lee JY; Choi YD; Chung BH; Hong SJ; Rha KH BJU Int; 2013 Jul; 112(2):216-23. PubMed ID: 23356436 [TBL] [Abstract][Full Text] [Related]
5. Robotic extended pelvic lymphadenectomy for intermediate- and high-risk prostate cancer. Yuh BE; Ruel NH; Mejia R; Wilson CM; Wilson TG Eur Urol; 2012 May; 61(5):1004-10. PubMed ID: 22366188 [TBL] [Abstract][Full Text] [Related]
6. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. Heidenreich A; Varga Z; Von Knobloch R J Urol; 2002 Apr; 167(4):1681-6. PubMed ID: 11912387 [TBL] [Abstract][Full Text] [Related]
7. Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy. Hansen J; Budäus L; Spethmann J; Schlomm T; Salomon G; Rink M; Haese A; Steuber T; Heinzer H; Huland H; Graefen M; Michl U Urology; 2012 Oct; 80(4):877-82. PubMed ID: 22950996 [TBL] [Abstract][Full Text] [Related]
8. Pathologic implications of prostatic anterior fat pad. Jeong J; Choi EY; Kang DI; Ercolani M; Lee DH; Kim WJ; Kim IY Urol Oncol; 2013 Jan; 31(1):63-7. PubMed ID: 21396837 [TBL] [Abstract][Full Text] [Related]
9. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy. Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707 [TBL] [Abstract][Full Text] [Related]
10. Detailed analysis of patients with metastasis to the prostatic anterior fat pad lymph nodes: a multi-institutional study. Kim IY; Modi PK; Sadimin E; Ha YS; Kim JH; Skarecky D; Cha DY; Wambi CO; Ou YC; Yuh B; Park S; Llukani E; Albala DM; Wilson T; Ahlering T; Badani K; Ahn H; Lee DI; May M; Kim WJ; Lee DH J Urol; 2013 Aug; 190(2):527-34. PubMed ID: 23485503 [TBL] [Abstract][Full Text] [Related]
11. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719 [TBL] [Abstract][Full Text] [Related]
12. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study. Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833 [TBL] [Abstract][Full Text] [Related]
13. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? Bader P; Burkhard FC; Markwalder R; Studer UE J Urol; 2003 Mar; 169(3):849-54. PubMed ID: 12576797 [TBL] [Abstract][Full Text] [Related]
14. Standardized and simplified extended pelvic lymph node dissection during robot-assisted radical prostatectomy: the monoblock technique. Mattei A; Di Pierro GB; Grande P; Beutler J; Danuser H Urology; 2013 Feb; 81(2):446-50. PubMed ID: 23374827 [TBL] [Abstract][Full Text] [Related]
15. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer. Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148 [TBL] [Abstract][Full Text] [Related]
16. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342 [TBL] [Abstract][Full Text] [Related]
17. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy. Arenas LF; Füllhase C; Boemans P; Fichtner J Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944 [TBL] [Abstract][Full Text] [Related]
18. The impact of prostate gland weight in robot assisted laparoscopic radical prostatectomy. Link BA; Nelson R; Josephson DY; Yoshida JS; Crocitto LE; Kawachi MH; Wilson TG J Urol; 2008 Sep; 180(3):928-32. PubMed ID: 18635217 [TBL] [Abstract][Full Text] [Related]
19. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement. Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258 [TBL] [Abstract][Full Text] [Related]